Statistics on Biotechnology Use Results by sector of operation Sector Companies. Results in biotechnology for main variables and branches of activity Unidades: specified in variables Total Companies Services Industry and Construction Agriculture No. of companies carrying out R&D in Biotechnology 1.078 695 298 85 %Companies according to biotechnology used: Genetic code 35 43 16 38 %Companies according to biotechnology used: Functional units 42 45 40 18 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 27 30 18 29 %Companies according to biotechnology used: Bioprocesses 49 41 72 32 %Companies according to biotechnology used: Sub-cellular organisms 8 10 4 1 %Companies according to biotechnology used: Bio-computing 22 30 6 7 %Companies according to biotechnology used: Nanobiotechnology 14 18 7 1 %Companies according to biotechnology used: Other 12 12 10 16 Companies in which biotechnology activities are: Main and/or exclusive 526 448 71 7 Companies in which biotechnology activities are: A secondary line of business 173 101 61 11 Companies in which biotechnology activities are: A tool necessary for production 379 146 166 68 %Company by field(s) of ultimate application of biotechnology use: Human Health 48 63 27 4 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 20 20 16 33 %Company by field(s) of ultimate application of biotechnology use: Food products 33 25 50 35 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 24 21 19 60 %Company by field(s) of ultimate application of biotechnology use: Environment 15 16 15 9 %Company by field(s) of ultimate application of biotechnology use: Industry 14 16 10 1 Personnel in R&D in biotechnology (no. of persons) 10.191 6.743 2.733 715 Personnel in R&D in biotechnology (no. of persons): Researchers 5.774 4.260 1.267 247 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 4.417 2.483 1.466 468 Personnel in R&D in biotechnology (no. of persons): women 5.525 3.876 1.350 298 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 3.015 2.286 637 91 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 2.511 1.590 713 207 Personnel in R&D in biotechnology (FTE) 7.191,4 4.952,9 1.826,7 411,7 Personnel in R&D in biotechnology (FTE): Researchers 4.276,6 3.198,6 917,6 160,4 Personnel in R&D in biotechnology (FTE): Technicians and assistants 2.914,7 1.754,3 909,1 251,3 Personnel in R&D in biotechnology (FTE): women 3.985,4 2.831,9 953,7 199,8 Personnel in R&D in biotechnology (FTE): (women) Researchers 2.234 1.696,3 475,9 61,8 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.751,4 1.135,6 477,9 137,9 Internal expenditure on R&D (thousands of euros) 578.171 395.589 159.179 23.403 1) By nature of the expense: Current expenses 517.601 349.562 146.112 21.927 1.1) Remuneration to researchers 213.755 151.067 55.410 7.278 1.2) Remuneration to technicians and assistants 98.440 55.120 36.579 6.741 1.3) Other current expenses 205.406 143.375 54.123 7.908 2) By nature of the expense: Capital expenses 60.570 46.027 13.067 1.476 2.1) Land and buildings 22.609 21.356 1.165 87 2.2) Equipment and instruments 36.169 22.930 11.860 1.379 2.3) Acquisition of specific R&D software 1.793 1.741 42 10 1) By origin of the funds: National funds 487.615 340.944 125.565 21.105 1.1) Own funds 330.459 193.495 117.264 19.701 1.2) From companies 45.462 42.794 2.668 . 1.3) Public Administration funds 66.189 59.179 5.605 1.405 1.4) From Universities 25.148 25.119 29 . 1.5) From non profit private institutions 20.357 20.357 . . 1) By origin of the funds: Foreign funds 90.556 54.645 33.614 2.298 2.1) From EU programmes 20.932 20.111 802 20 2.2) Other foreign funds 69.624 34.534 32.812 2.278 Purchase of R&D services in biotechnology (thousands of euros) 166.022 90.846 73.316 1.860 Purchase of R&D services in biotechnology (thousands of euros): In Spain 97.455 49.037 47.171 1.247 Purchase of R&D services in biotechnology (thousands of euros): Abroad 68.567 41.809 26.144 614 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 46 54 32 31 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 13 12 17 14 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 14 14 15 12 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 14 16 11 7 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 17 20 12 14 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 17 20 11 11 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 18 18 17 20 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 35 36 36 28 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 49 51 43 51 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 21 22 19 19 % Companies that have requested biotechnology patents in Biotechnology 15 19 10 5 Number of patents requested 526 390 99 37 % Companies with income of an international origin related to biotechnological activities 26 27 25,7 18,9 % Turnover representing income of an international origin related to biotechnological activities 1,4 6,6 1,1 1,3 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 63,8 44,1 72,2 67 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 36,2 55,9 27,8 33 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 91,6 76,6 98,5 77,6 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 0,9 0,5 0,4 22,4 % Income of an international origin related with activities according to the classification: Operating source abroad 1,9 5,7 0,3 . % Income of an international origin related with activities according to the classification: Other 5,6 17,2 0,8 . Notas: . '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute